Weight Loss Drugs arent “the answer”
Sheffield DPH
FEBRUARY 21, 2024
Do Health Economics 101 and read the TA, section 4 esp the discrepancy between manufacturers model assumptions vs committee central base case 3. 2% could be higher depending on the population group who end up taking the drug (when you think about other risk factors for gallstones e.g. women, over 40). Medicalises a social issue.
Let's personalize your content